Brill Capital

BOZE Family Office was founded in Beijing in 2009 to manage one family's assets and succession. It invests in public and private markets in China and overseas, including through specialist private funds. BOZE says it manages more than RMB 4 billion in owned assets.

Hillhouse is a global investment firm that began investing in public equities, later added a private-equity strategy, and now invests across all stages of company life cycles.

CDH Investments is a diversified alternative asset manager with private-equity, venture-and-growth, private-credit, public-equity, and real-asset activities; VGC is its venture-and-growth unit.

InnoHub Capital is a venture investor and startup accelerator that backs technology startups and provides incubation, acceleration, education, events, and networking services, with an emphasis on opportunities in China.

CoStone Capital is a Shenzhen-headquartered Chinese private markets manager. Its strategy spans early venture and private equity, including growth investments and buyouts.

Hankang Capital is a venture capital arm of Zhongjianxin Group focused on biomedicine and related healthcare fields, including medical equipment, diagnostics and medical services.

Lilly Asia Ventures is a biomedical venture capital firm that originated in 2008 as an Eli Lilly corporate venture subsidiary and later became an independent investment manager.